Related Experiment Video
Updated: Jun 16, 2026
03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Upper respiratory infections: treatment selection for active patients
The Physician and Sportsmedicine
|January 21, 2010
Summary
Moderate exercise may lower infection risk, while intense training can increase it. Colds typically don't hinder athletes, but symptom relief and avoiding banned substances are key for performance.
Area of Science:
- Exercise physiology
- Sports medicine
- Infectious disease
Background:
- Upper respiratory tract infections (URTIs) are common in athletes.
- The relationship between exercise intensity and URTI risk is complex.
- Managing URTI symptoms in athletes requires careful consideration of performance and anti-doping regulations.
Purpose of the Study:
- To review the impact of exercise on URTI risk.
- To discuss symptomatic treatment options for athletes with colds.
- To highlight considerations regarding medications and sports regulations.
Main Methods:
- Literature review of studies on exercise and URTIs.
- Analysis of current treatment guidelines for URTIs.
- Examination of sports anti-doping lists for relevant medications.
Main Results:
- Moderate exercise is associated with reduced URTI risk; intense training may increase it.
- Topical decongestants and ipratropium bromide may offer symptomatic relief for active individuals.
- Vitamin C and zinc may shorten cold duration.
- Antibiotics are ineffective for viral URTIs but necessary for bacterial complications.
- Certain medications, like first-generation antihistamines, can impair athletic performance and are banned by sports organizations.
Conclusions:
- Athletes should balance exercise intensity to minimize URTI risk.
- Symptomatic treatment for URTIs in athletes should prioritize safety and performance.
- Careful medication selection is crucial to avoid performance impairment and anti-doping rule violations.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Acute Pharyngitis
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...